Durvalumab with or Without Tremelimumab for Patients with Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
- Eileen M. O'Reilly
- , Do Youn Oh
- , Neesha Dhani
- , Daniel J. Renouf
- , Myung Ah Lee
- , Weijing Sun
- , George Fisher
- , Aram Hezel
- , Shao Chun Chang
- , Gordana Vlahovic
- , Osamu Takahashi
- , Yin Yang
- , David Fitts
- , Philip Agop Philip
- Memorial Sloan-Kettering Cancer Center
- Seoul National University
- Ontario Cancer Institute
- Provincial Health Services Authority
- University of Kansas
- Stanford University
- University of Rochester
- AstraZeneca
- Independent Biostatistician
- Wayne State University
Research output: Contribution to journal › Article › peer-review
623
Scopus
citations